Shield Therapeutics: Funding, Investors & Team (Oct 2026)
Shield Therapeutics is a specialized pharmaceutical company that is dedicated to creating and selling advanced hospital medications derived from minerals, which target areas of medical need that have not been adequately addressed. In 2011, Shield will begin conducting critical Phase III trials worldwide for its primary product, ST10-021, designed to treat iron deficiency anemia caused by inflammatory bowel disease and later chronic kidney disease. The company is based in Wollerau, Switzerland.
Shield Therapeutics has raised $20.0M across 1 funding round on record, the most recent an undisclosed round of $20.0M announced in Sep 2023.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Shield Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2023.
Shield Therapeutics Funding Rounds
Shield Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Shield Therapeutics Funding Compared to Other Biotechnology Startups
Shield Therapeutics' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Shield Therapeutics in Biotechnology and Weybridge
Companies Similar to Shield Therapeutics
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Shield Therapeutics Funding FAQs
What does Shield Therapeutics do?
Shield Therapeutics is a specialized pharmaceutical company that is dedicated to creating and selling advanced hospital medications derived from minerals, which target areas of medical need that have not been adequately addressed. In 2011, Shield will begin conducting critical Phase III trials worldwide for its primary product, ST10-021, designed to treat iron deficiency anemia caused by inflammatory bowel disease and later chronic kidney disease. The company is based in Wollerau, Switzerland.
How much funding has Shield Therapeutics raised?
Shield Therapeutics has raised $20.0M across 1 round on record. The most recent is an undisclosed round of $20.0M announced in Sep 2023.
When did Shield Therapeutics last raise funding?
Shield Therapeutics' most recent funding round on record is an undisclosed round of $20.0M, announced in Sep 2023.
Who founded Shield Therapeutics?
FundedIQ lists Christian Schweiger (Founder) at Shield Therapeutics.
Where is Shield Therapeutics headquartered?
Shield Therapeutics is based in Weybridge, Surrey, United Kingdom.
How many employees does Shield Therapeutics have?
Shield Therapeutics is in the 51-100 employee band.
How does Shield Therapeutics' funding compare to other Biotechnology startups?
Shield Therapeutics' latest round of $20.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Shield Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Shield Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.